TREATMENT OF MALIGNANT TUMOURS WITH 5-FLUOROURACIL IN 80 PATIENTS.
D035843:Biomedical Research; D001943:Breast Neoplasms; D003110:Colonic Neoplasms; D004358:Drug Therapy; D004938:Esophageal Neoplasms; D005260:Female; D005472:Fluorouracil; D005770:Gastrointestinal Neoplasms; D006689:Hodgkin Disease; D006801:Humans; D007680:Kidney Neoplasms; D008175:Lung Neoplasms; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D016685:Mitomycin; D009369:Neoplasms / Q000532:radiotherapy* / Q000628:therapy*; D010051:Ovarian Neoplasms; D010190:Pancreatic Neoplasms; D010610:Pharyngeal Neoplasms; D012004:Rectal Neoplasms; D012509:Sarcoma; D013274:Stomach Neoplasms; D014116:Toxicology; D001749:Urinary Bladder Neoplasms
D016685:Mitomycin; D005472:Fluorouracil
BLADDER NEOPLASMS; BREAST NEOPLASMS; CLINICAL RESEARCH; COLONIC NEOPLASMS; DRUG THERAPY; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; GASTROINTESTINAL NEOPLASMS; HODGKIN'S DISEASE; KIDNEY NEOPLASMS; LUNG NEOPLASMS; LYMPHOSARCOMA; MITOMYCIN; NEOPLASM RADIOTHERAPY; NEOPLASM THERAPY; NEOPLASMS; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PHARYNGEAL NEOPLASMS; RECTAL NEOPLASMS; SARCOMA, RETICULUM CELL; STOMACH NEOPLASMS; TOXICOLOGIC REPORT